Insights

Developing a 1-year heart failure (HF) risk model using clinical and lab data improves prediction accuracy. This model identifies new predictors and clarifies hypertension's role in short-term HF risk.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Biostatistics

Background:

  • Validated risk scores for short-term heart failure (HF) incidence are limited.
  • Accurate prediction models are crucial for timely intervention and patient management.

Purpose of the Study:

  • To develop and validate a 1-year HF incidence risk prediction model.
  • To assess the added value of laboratory variables to clinical risk factors for HF prediction.

Main Methods:

  • Utilized the MIMIC II clinical database.
  • Developed two multivariable Cox models: one with clinical factors, another including laboratory parameters (serum creatinine, BUN, glucose, PT, APTT, TBIL).
  • Internally validated model performance using bootstrapping.

Main Results:

  • Identified pulmonary circulation diseases, peripheral vascular disease, chronic pulmonary disease, hypothyroidism, electrolyte/fluid disorders, BUN, and APTT as independent predictors of HF incidence.
  • Found hypertension has an inverse association with short-term HF risk.
  • The combined model achieved a C-statistic of 0.712 with internal validation, demonstrating effectiveness.

Conclusions:

  • A prediction model incorporating both clinical and laboratory factors enhances 1-year HF risk assessment.
  • Several clinical and laboratory indices, beyond traditional factors, are significant predictors of short-term HF.
  • Hypertension's complex role in short-term HF risk warrants further investigation.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
631
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
954
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
785